Big Data, Big Biology, and the ‘Tipping Point’ in Quantified Health

Applied Proteomics visualisation

offer experiences that people embrace, and I think the way you do that is by starting really, really simple.”

Topol also raised another key issue—cost—saying technology innovations almost invariably increase the cost of health care.

“I had a really interesting dinner last week with Bill Gates,” Topol said, “and I was shocked because he was questioning all this stuff. He was saying, ‘Show me where it’s going to cut costs.”

“The only thing that’s ever proven to save costs is something that’s been preventive—so things like vaccines and pap smears,” said Drew Senyei of San Diego’s Enterprise Partners Venture Capital. “Prevention is the only way we’re going to bring costs down.”

“The cost of being able to match a [person’s disease] to a drug is much less than the actual cost of the drug itself,” said Shawver. “And the most expensive drug is the one that doesn’t work. Often times people go from drug to drug to drug in a trial-and-error approach that adds a lot to costs. But it the past, the ability to gain [personalized genetic] information has not been cost-effective.”

The cost issue is important, but a pilot program that demonstrates the potential of quantified health could open the way for more ambitious efforts, said Peter Ellsworth, president of the Legler Benbough Foundation, a $35 million fund that awards grants to improve the quality of life of in San Diego. Ellsworth, who retired in 1996 after a 10-year reign as the CEO of Sharp Healthcare, says a successful demonstration also could help lower the competitive tensions between San Diego’s three rival health systems: Sharp, Scripps Health, and the UC San Diego Health System.

“If somebody is doing something and people like it, and there’s some publicity, pretty soon, the others will come along,” Ellsworth said. “I think the technology really does offer us something that we haven’t had before, because we’re going to be able to demonstrate things we were never able to do before.”

Rivalries between doctors and healthcare systems also could become less relevant as people generate more of their own health data from devices like Fitbit and BodyMedia, said Smarr. He estimates that 25 percent of all medical test data now resides outside the confines of health care systems, and that it is only going to increase. So now is the time to start thinking about the scale of quantified health and how it’s going to work.

“We’ve got to find a way to make your own data transportable, and we’ve got to have the legal reforms so that

Author: Bruce V. Bigelow

In Memoriam: Our dear friend Bruce V. Bigelow passed away on June 29, 2018. He was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Bruce Bigelow joined Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University. Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.